NCT05674058View on ClinicalTrials.gov

Function and Imaging Assessments for G1961E-associated Stargardt Disease

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Stargardt DiseaseStargardt Disease 1Fundus FlavimaculatusMacular Degeneration, StargardtMacular Dystrophy With Flecks, Type 1
Interventions
OTHER

No intervention

According to clinical practice.

Trial Locations (1)

CH-4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER